Rosuvastatin calcium (CAS 147098-20-2, molecular formula being C44H54CaF2N6O12S2) is the active pharmaceutical ingredient for the once-a-day dyslipidaemia treatment Crestor, it is one approved API which can be used to reduce the risk of heart attack and stroke.Rosuvastatin calcium is a hygroscopic powder suitable for the manufacture of tablets and capsules. The appropriate excipients need to be added. The particle size of the product is designed in such a way that optimal dissolution can be obtained (depending on formulation).
With the raw material advantage, EU is the dominate producer and exporter in rosuvastatin calcium industry. The production market share of EU has reached about 35.25% in 2015. In additional, EU is also the largest consumer of rosuvastatin calcium, about 34.47% of the global production was consumed in EU in 2015. China is the second producer with the market share of 28.82% in 2015. Top Three manufacturers in rosuvastatin calcium are AstraZeneca, MSN Laboratories, Changzhou Pharmaceutical Factory, according for 55.09% of the total amount in 2015.
According to this study, over the next five years the Rosuvastatin Calcium market will register a 4.1% CAGR in terms of revenue, the global market size will reach US$ 550 million by 2024, from US$ 430 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rosuvastatin Calcium business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Rosuvastatin Calcium market by product type, application, key manufacturers and key regions and countries.
This study considers the Rosuvastatin Calcium value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Purity 98.0%
Purity 99.0%
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Tablet (including dispersible tablet and general tablet)
Capsule
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AstraZeneca
Teva Pharmaceutical Industries
MSN Laboratories
Cadila Pharmaceuticals
LGM Pharma
Bal Pharma
Changzhou Pharmaceutical Factory
Jingxin Pharm
Zhejiang Hisun Pharmaceutical
HEC Pharm
Lunan Pharmaceutical
Nanjing Frochem Tech
Lianyungang Runzhong Pharmaceutical
Shandong Bechem Chemicals
CTX Life Sciences
Others
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rosuvastatin Calcium consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rosuvastatin Calcium market by identifying its various subsegments.
Focuses on the key global Rosuvastatin Calcium manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rosuvastatin Calcium with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rosuvastatin Calcium submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Summary:
Get latest Market Research Reports on Rosuvastatin Calcium . Industry analysis & Market Report on Rosuvastatin Calcium is a syndicated market report, published as Global Rosuvastatin Calcium Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Rosuvastatin Calcium market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.